Autoimmune thyroid disease is the archetype of organ-specific autoimmu
ne disorders and shares with them T cell dependence. The observation t
hat thyroid cells in autoimmune thyroid disease express the major hist
ocompatibility complex molecule HLA-DR led to the hypothesis that they
could present antigen and initiate or maintain the autoimmune process
. However, functional experiments, and recent evidence indicating that
provision of a co-stimulatory signal is also essential for efficient
antigen presentation, argue against such a role. The analysis of T cel
l responses to two major thyroid antigens, thyroid peroxidase and the
thyroid stimulating hormone receptor, reveals a heterogeneity both wit
hin and between patients, and intrathyroidal T cells show diverse usag
e of T cell receptor genes. Therefore, any strategy that uses modified
peptides, monoclonal antibodies against specific T cell, receptor mol
ecules, or T cell vaccination for the purpose of treating thyroid auto
immunity is unlikely to succeed.